Claim OwnershipOnCall
Subscribed: 7Played: 54
Subscribe
© 2025 OnCall
Description
A podcast from Cencora where we discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go. OnCall will make it easy for you to access the education you want - whenever you want.
51 Episodes
Reverse
In this episode, Joel White, Partner and Head of Health Practice at Monument Advocacy, will discuss the Medicare physician fee schedule proposed rule and impact on practices and manufacturers, end of the year health priorities for congress, and Trump Administration goals, plans and efforts on drug pricing/MFN. If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and no...
In this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to help its customer prepare for IRA deadlines. For IRA specific questions, please reach out to IRAsupport@cencora.com. If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional...
In this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms for value-based care, CMS focus on technology assisted care, and drug price reforms. If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical ju...
In this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty GPO Portfolio Accounts, will give an overview of IRA and dive into IRA impact on patients, manufacturers, and providers. If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medic...
In this episode, the final of our 505(b)(2) series, sponsored by Avyxa, we are joined by Dr. Fred Divers, Chief Medical Officer for American Oncology Network, and Dr. Ralph Boccia, hematologist oncologist, member of American Oncology Network, and the International Oncology Network's Chief Medical Officer, who will discuss operationalizing in practice from a provider perspective. If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com. Disclaimer...
In this episode, the fourth of our 505(b)(2) series, sponsored by Avyxa, we are joined by James Gilmore, Chief Pharmacy and Clinical Services Officer at American Oncology Network, and Joe Shupp, VP of Sales for Cencora's ION Oncology Network, who will discuss operationalizing in practice from a pharmacist perspective. If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only an...
In this episode, the third of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Trey McNiel, Senior Director of Sales for Cencora's ION Oncology Network East Region, discuss billing and reimbursement of 505(b)(2)s. If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com. Discla...
In this episode, the second of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Matthew Letow, Senior Director of Sales New Business Development for Cencora's SAN GPO National Accounts, who will discuss the landscape and pipeline of 505(b)(2)s. If you have questions for our guests or suggestions for future topics, send us an emai...
In this episode, the first of our 505(b)(2) series, sponsored by Avyxa, we are joined by Zach Horstman, Director of Specialty GPO Corporate Accounts for Cencora, and Yoni Resnick, Director of Pharmacy Clinical Services at New England Cancer Specialists, who will discuss the basics of 505(b)(2)s. If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for ...
In this episode, we are joined by Cencora's Specialty Practice Network National Senior Director of Sales for Immunology, Chara Reid, VP Sales for Cencora's Specialty Practice Network, Kortney Cooper, and Elizabeth Johnson, CEO of MedicoCX, who will discuss how buy and bill is implemented in MedicoCX practices. If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and not ...
In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill. To find a copy of Kortney's presentation, please visit our OnCall page under Clinical Education on our ION and Specialty Practice Network websites. If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and not a ...
In this episode, we are joined by Joel White, President of Horizon Government Affairs, who will discuss the Inflation Reduction Act, PBM reform, drug shortages, Medicare physician payment and telehealth issues. If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com. Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only ...
In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars. Our next episode will feature information on the biosimilar payer perspective. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market. Our next episode will feature information on biosimilar legislation. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed. Our next episode will feature information on the current Biosimilar landscape and what we can expect to see in the market. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services. Our next episode will feature information on drug pricing and shortages. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform. Our next episode will feature information on transparency in the House, competition, and lower costs on drugs and services. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections. That's all for this episode of OnCall. Our next episode will feature information on politics and policy, and physician payment issues. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.
Comments
Download from Google Play
Download from App Store
United States